Chemclin Diagnostics Co. Ltd. A
Chemclin Diagnostics Co., Ltd. engages in the research and development, production, and sale of clinical immune chemiluminescence diagnostic reagents and instruments. Its products include LiCAA series of diagnostic reagents based on photo-induced chemiluminescence and CC series based on enzymatic chemiluminescence diagnostic reagents and instruments, primarily used for infectious diseases, such a… Read more
Chemclin Diagnostics Co. Ltd. A (688468) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.024x
Based on the latest financial reports, Chemclin Diagnostics Co. Ltd. A (688468) has a cash flow conversion efficiency ratio of 0.024x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥34.41 Million) by net assets (CN¥1.41 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Chemclin Diagnostics Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Chemclin Diagnostics Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Chemclin Diagnostics Co. Ltd. A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chemclin Diagnostics Co. Ltd. A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lydia Yesil Enerji Kaynaklari A.S.
IS:LYDYE
|
N/A |
|
Guilin Tourism Corp Ltd
SHE:000978
|
0.059x |
|
Beijing Jiuzhou Yi Gui Environmental Technology Co. Ltd.
SHG:688485
|
N/A |
|
Zhang Xiaoquan Inc.
SHE:301055
|
N/A |
|
Xinjiang Tianshun Supply Chain Co Ltd
SHE:002800
|
-0.079x |
|
Shanghai Hile Bio-tech
SHG:603718
|
-0.001x |
|
Duni AB (publ)
PINK:DUNNF
|
0.044x |
|
Talon Capital Corp. Class A Ordinary Shares
NASDAQ:TLNC
|
N/A |
Annual Cash Flow Conversion Efficiency for Chemclin Diagnostics Co. Ltd. A (2017–2024)
The table below shows the annual cash flow conversion efficiency of Chemclin Diagnostics Co. Ltd. A from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.42 Billion | CN¥167.95 Million | 0.119x | -4.83% |
| 2023-12-31 | CN¥1.39 Billion | CN¥173.05 Million | 0.125x | -29.66% |
| 2022-12-31 | CN¥1.38 Billion | CN¥244.56 Million | 0.177x | +19.94% |
| 2021-12-31 | CN¥1.28 Billion | CN¥188.86 Million | 0.148x | -13.75% |
| 2020-12-31 | CN¥887.36 Million | CN¥151.95 Million | 0.171x | -26.24% |
| 2019-12-31 | CN¥866.97 Million | CN¥201.27 Million | 0.232x | +21.89% |
| 2018-12-31 | CN¥775.38 Million | CN¥147.68 Million | 0.190x | -7.66% |
| 2017-12-31 | CN¥647.08 Million | CN¥133.46 Million | 0.206x | -- |